PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
PAVmed (PAVM) is a medical device company with a fast-moving business model. The company intends to speed up the time it takes to get medical devices on the market ...
report provides actionable intelligence on factors that have been driving demand; key trends that are impacting the market; challenges that affect the market dynamics along with the market size, a ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results